United States — Food and Drug Administration & Nasdaq-100
17 shared events · Importance 3 · Last updated May 14, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Nasdaq-100: ImmunityBio's stock is traded on Nasdaq-100, where its stock price fell significantly after the United States — Food and Drug Administration's warning became public.
Apr 02, 2026 · 132 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration approved Eli Lilly and Company's weight loss pill, Foundayo, impacting the pharmaceutical market.
Nasdaq-100: The Nasdaq-100 exchange also experienced more advancing issues than decliners, contributing to the overall positive market performance.
Apr 01, 2026 · 14 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration placed a full clinical hold on MiNK Therapeutics' investigational new drug application for ARD-101, directly impacting the company's drug development and stock performance.
Nasdaq-100: Nasdaq-100 is the exchange where MiNK Therapeutics' stock is traded, reflecting the significant price drops related to the event.
May 21, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.
Nasdaq-100: Nasdaq-100 is the stock exchange where Aldeyra Therapeutics's shares are traded.
Apr 24, 2026 · 80 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's delayed clearance for Caris Life Sciences' TriNav Advance product is a key factor contributing to the company's financial issues and the subsequent investor investigations.
Nasdaq-100: Nasdaq-100 is the stock exchange where Caris Life Sciences Inc. is publicly traded, and its stock price decline was observed on this exchange.
Jun 02, 2026 · 31 articles
Business
United States — Food and Drug Administration: Bluejay Diagnostics intends to use the net proceeds to fund matters related to obtaining FDA approval for its products, which is crucial for its commercialization efforts.
Nasdaq-100: The private placement was priced at-the-market under Nasdaq-100 rules, indicating compliance with its regulatory framework.
Jun 02, 2026 · 10 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration approved PEDMARK, a key product of Fennec Pharmaceuticals, which provides background on the company's operational success.
Nasdaq-100: The stock options were granted in accordance with Nasdaq-100 Listing Rule 5635(c)(4), indicating compliance with exchange regulations.
May 18, 2026 · 7 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration is currently reviewing the New Drug Application for rusfertide for the treatment of polycythemia vera.
Nasdaq-100: Nasdaq-100 is the exchange where AnBogen Therapeutics common stock is traded, and its rules govern the granting of inducement awards.
Jun 16, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Therapy designation to Cadisegliatin, highlighting its potential importance in treating type 1 diabetes. This designation adds credibility to vTv Therapeutics's pipeline.
Nasdaq-100: Nasdaq-100 is mentioned as the exchange where vTv Therapeutics is listed and its rules (Nasdaq-100 Listing Rule 5635(c)(4)) govern the inducement grants.
Jun 02, 2026 · 7 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration has cleared the NeuroStar Advanced Therapy System for various neurohealth conditions, providing regulatory approval for Neuronetics' key product.
Nasdaq-100: Nasdaq-100 is the stock exchange where Neuronetics is listed, and its listing rules govern the inducement grant to Robert Greenberg.
Jun 02, 2026 · 6 articles
Business
Nasdaq-100: Nasdaq-100 is the stock exchange where Rhythm Pharmaceuticals, Inc. securities are traded.
Apr 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Nasdaq-100 interact across events, view sentiment trends, and discover connected entities.
Open Dashboard